Organon & Co | OGN - EPS Earnings Per Share


Organon & Co reported $0.71 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.90 1.01 Oct/29
FY2026Q2 Jun/2026 0.89 1.00 Aug/11
FY2026Q1 Mar/2026 0.71 0.83 1.02 Apr/30
FY2025Q4 Dec/2025 0.63 0.76 0.90 Feb/12
FY2025Q3 Sep/2025 1.01 0.94 0.87 Nov/10




Eps Change Date
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Celltrion KRW 1.35K 224.25 Jun/2026
Cspc Pharmaceutical CNY 0.08 0.08 Mar/2026
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Divis Laboratories Ltd INR 28.29 6.31 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Kangmei Pharma CNY 0 0 Mar/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Novartis USD 1.99 0.45 Mar/2026
Organigram Holdings CAD -0.01 0.15 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pharma Mar EUR 0.09 3.25 Mar/2026
Qiagen NV USD 0.46 0.06 Mar/2026
Sartorius EUR 0.95 0.25 Jun/2026
Sino Biopharmaceutical CNY -0.06 0.22 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Zealand Pharma A/S -8.34 2.6 Dec/2025